MEET THE TEAM

Dana Lagman is a Clinical Quality Assurance professional with extensive experience in global audits, inspection readiness, and clinical trial oversight. She has led comprehensive audit programs covering investigator sites, vendors, CROs, and internal processes, ensuring compliance with ICH GCP, FDA regulations, ISO 13485, ISO 9001, and 21 CFR 820. Her audit work extends across the full study lifecycle, from vendor qualification and risk assessments to ongoing oversight and end-of-study reviews, with a strong record of driving effective CAPA implementation and maintaining inspection-ready documentation.

 

In addition to her quality expertise, Dana brings hands-on clinical research experience, supporting studies from protocol development and case report form design to site monitoring, data integrity review, and study closeout. She has authored and maintained essential trial documentation, managed regulatory submissions and registrations, coordinated with CROs, investigators, and regulatory stakeholders, and contributed to high-quality study outputs.

 

Her combined background in quality, regulatory, and clinical operations allows her to bridge operational teams with regulatory expectations, ensuring compliance while enabling the successful execution of diverse clinical studies. Dana’s educational background is in Biochemistry, and she is certified in Good Clinical Practice (GCP).

​

Outside of work, Dana enjoys camping with her dogs, collecting plants, organizing, and exploring interior design ideas.